Dr. Reddy's Laboratories
146 hedge funds and large institutions have $924M invested in Dr. Reddy's Laboratories in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 22 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 43
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 49.99% → 49.9% (-0.09%)
1% less funds holding
Funds holding: 147 → 146 (-1)
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
15% less capital invested
Capital invested by funds: $1.08B → $924M (-$159M)
21% less call options, than puts
Call options by funds: $424K | Put options by funds: $535K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$22.9M |
| 2 |
JP Morgan Chase
New York
|
+$20.6M |
| 3 |
Morgan Stanley
New York
|
+$14.4M |
| 4 |
Goldman Sachs
New York
|
+$10.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$8.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$37.5M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$24.5M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$14.7M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9.29M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$8.61M |
RDY Hedge Fund Activity: Q1 2022 in Review
146 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2022, worth a combined $924M — down 15% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of RDY and 21 opened new positions — a net loss of 1 holder — while 43 trimmed existing stakes and 52 added.
The largest buyer was Millennium Management, adding an estimated $22.9M. The largest seller was Schroder Investment Management Group, cutting an estimated $37.5M.
- 146 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2022, down from 147 in Q4 2021.
- Funds reported $924M of Dr. Reddy's Laboratories stock for Q1 2022, down 15% quarter-over-quarter.
- 21 funds opened new Dr. Reddy's Laboratories positions in Q1 2022 and 22 closed out, a net change of -1 holder.
- The largest Dr. Reddy's Laboratories buyer in Q1 2022 was Millennium Management, an estimated $22.9M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2022 was Schroder Investment Management Group, an estimated $37.5M sold.
Based on aggregated 13F filings for Q1 2022.